PainReform Ltd (NASDAQ:PRFX) has a beta value of 0.60 and has seen 2.33 million shares traded in the recent trading session. The company, currently valued at $2.56M, closed the recent trade at $1.27 per share which meant it lost -$0.2 on the day or -13.84% during that session. The PRFX stock price is -1209.45% off its 52-week high price of $16.63 and -14.96% below the 52-week low of $1.46. If we look at the company’s 10-day average daily trading volume, we find that it stood at 43470.0 shares traded. The 3-month trading volume is 1.33 million shares.

PainReform Ltd (NASDAQ:PRFX) trade information

Sporting -13.84% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the PRFX stock price touched $1.27 or saw a rise of 27.75%. Year-to-date, PainReform Ltd shares have moved -89.39%, while the 5-day performance has seen it change -26.16%. Over the past 30 days, the shares of PainReform Ltd (NASDAQ:PRFX) have changed -35.53%. Short interest in the company has seen 0.18 million shares shorted with days to cover at 0.55.

PainReform Ltd (PRFX) estimates and forecasts

The company’s shares have lost -88.62% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 12.33% over the past 5 years.

PRFX Dividends

PainReform Ltd is expected to release its next earnings report on 2024-Aug-15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

PainReform Ltd (NASDAQ:PRFX)’s Major holders

Insiders own 9.62% of the company shares, while shares held by institutions stand at 2.17% with a share float percentage of 2.40%. Investors are also buoyed by the number of investors in a company, with PainReform Ltd having a total of 5.0 institutions that hold shares in the company.